These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36916184)

  • 1. Letter to "Chepelev et al. Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose-response data: Margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose-response data".
    Thompson CM; Proctor DM; Harris MA
    Environ Mol Mutagen; 2023 Apr; 64(4):259-260. PubMed ID: 36916184
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose-response data: Margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose-response data.
    Chepelev N; Long AS; Beal M; Barton-Maclaren T; Johnson G; Dearfield KL; Roberts DJ; van Benthem J; White P
    Environ Mol Mutagen; 2023 Jan; 64(1):4-15. PubMed ID: 36345771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents.
    Rosenkranz HS; Klopman G
    Environ Mol Mutagen; 1993; 21(2):193-206. PubMed ID: 8444146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of mutagenicity and carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in F344 gpt delta transgenic rats.
    Gi M; Fujioka M; Totsuka Y; Matsumoto M; Masumura K; Kakehashi A; Yamaguchi T; Fukushima S; Wanibuchi H
    Mutagenesis; 2019 Sep; 34(3):279-287. PubMed ID: 31233596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.
    Buist H; Aldenberg T; Batke M; Escher S; Klein Entink R; Kühne R; Marquart H; Pauné E; Rorije E; Schüürmann G; Kroese D
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):170-81. PubMed ID: 23357514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent carcinogenicity and toxicity, in vitro mutagenicity, and their physical chemical determinants.
    Benigni R; Andreoli C
    Mutat Res; 1993 Oct; 297(3):281-92. PubMed ID: 7692274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic chemicals: their significance.
    McGregor D
    Biotherapy; 1998; 11(2-3):169-80. PubMed ID: 9677048
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for the mutagenicity and carcinogenicity of simple and alpha-beta unsaturated aldehydes.
    Benigni R; Passerini L; Rodomonte A
    Environ Mol Mutagen; 2003; 42(3):136-43. PubMed ID: 14556221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
    Petkov PI; Patlewicz G; Schultz TW; Honma M; Todorov M; Kotov S; Dimitrov SD; Donner EM; Mekenyan OG
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):17-25. PubMed ID: 25792138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The parallelogram approach in studies of genotoxic effects.
    Anderson D; Sorsa M; Waters MD
    Mutat Res; 1994; 313(2-3):101-15. PubMed ID: 7523897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
    Klopman G; Rosenkranz HS
    Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical parameters for quantification of mutational responses in bacteria.
    Roldán-Arjona T; Pueyo C; Haynes RH
    Mutat Res; 1995 Feb; 346(2):77-84. PubMed ID: 7885403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.
    Thresher A; Foster R; Ponting DJ; Stalford SA; Tennant RE; Thomas R
    Regul Toxicol Pharmacol; 2020 Oct; 116():104749. PubMed ID: 32777431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity-carcinogenicity as related to teratogenic activity.
    Alia M; Laborda E; Antón FA
    Bull Environ Contam Toxicol; 1992 Feb; 48(2):275-81. PubMed ID: 1531619
    [No Abstract]   [Full Text] [Related]  

  • 16. Vinyl bromide.
    IARC Monogr Eval Carcinog Risks Hum; 1999; 71 Pt 2(PT 2):923-8. PubMed ID: 10476478
    [No Abstract]   [Full Text] [Related]  

  • 17. 1,2-Epoxybutane.
    IARC Monogr Eval Carcinog Risks Hum; 1999; 71 Pt 2(PT 2):629-40. PubMed ID: 10476465
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aziridine.
    IARC Monogr Eval Carcinog Risks Hum; 1999; 71 Pt 2(PT 2):337-44. PubMed ID: 10476450
    [No Abstract]   [Full Text] [Related]  

  • 20. MicotoXilico: An Interactive Database to Predict Mutagenicity, Genotoxicity, and Carcinogenicity of Mycotoxins.
    Tolosa J; Serrano Candelas E; Vallés Pardo JL; Goya A; Moncho S; Gozalbes R; Palomino Schätzlein M
    Toxins (Basel); 2023 May; 15(6):. PubMed ID: 37368656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.